Caprock Group’s Alpha Tau Medical DRTS Stock Holding History

Caprock Group’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,323	Closed	-$59K	–	921
2024 Q2	$59K	Buy	+23,323	New	+$59.3K	﹤0.01%	838

Other funds holding DRTS

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAM

Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Caprock Group's DRTS Position: Q3 2024 in Review

Caprock Group sold out of Alpha Tau Medical (DRTS) in Q3 2024, closing a stake of 23,323 shares — an estimated $59K sold.

Caprock Group first reported a position in DRTS in Q2 2024 and held it in 1 quarter. The position peaked at $59K in Q2 2024. 23 funds tracked by Wall St. Rank hold DRTS as of Q3 2024.

Caprock Group reported no remaining Alpha Tau Medical position as of Q3 2024 after selling out during the quarter.
Caprock Group sold 23,323 Alpha Tau Medical shares in Q3 2024, an estimated $59K.
Caprock Group first reported a position in Alpha Tau Medical in Q2 2024 and held it in 1 quarter.
Caprock Group's Alpha Tau Medical position peaked at $59K in Q2 2024.
23 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2024.

Based on Caprock Group's 13F filing for Q3 2024, filed 7 Nov 2024.